Testing new diagnostic criteria for optic nerve inflammation
Part of Brain & nervous system, Eyes & vision clinical trials.
This study evaluates new guidelines for diagnosing optic neuritis, a condition where the nerve that carries vision becomes inflamed. If you have sudden vision loss in one or both eyes and your doctor thinks optic neuritis might be the cause, this trial will help confirm the diagnosis using updated diagnostic criteria.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have sudden or gradual vision loss or vision problems related to the optic nerve in one or both eyes
- Your doctor believes optic neuritis is a possible cause of your vision problem
- Your vision symptoms started within the last 90 days
- You have not been enrolled in this study before
- You are willing to undergo diagnostic evaluation as part of the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the eye-to-brain visual pathways work in people who have had optic neuritis symptoms for less than 4 weeks. It may help researchers better understand neuro-inflammatory (nerve inflammation) disorders and improve future care.
This study uses a new type of MRI to look at the optic nerve in people who have vision loss from optic neuritis. It may help doctors understand your condition better without extra procedures.
This study tests whether a new medication called privosegtor can help restore vision in people who recently experienced sudden vision loss in one eye due to optic nerve inflammation. You would receive the study drug early after your symptoms start, when treatment may be most effective.
This study aims to create a tool to predict how people recover after an episode of optic neuritis (inflammation of the optic nerve). If you've had optic neuritis before, joining this research could help doctors better understand what to expect and provide more tailored care.
This Phase 2 trial tests whether clemastine can help regrow the protective covering around the optic nerve after acute optic neuritis (an inflammation-related vision problem). It may help improve vision recovery and signal how well “remyelination” happens.
This trial tests a drug called efgartigimod for people having their first episode of optic neuritis (inflammation of the optic nerve). The goal is to see if it can help protect your vision better than standard treatment alone.
Hear when a new Optic Neuritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.